Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NARATRIPTAN vs NATAMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NARATRIPTAN vs NATAMYCIN: Safety Overview

Metric NARATRIPTAN NATAMYCIN
Total FAERS Reports 526 258
Deaths Reported 9 61
Death Rate 1.7% 23.6%
Hospitalizations 102 101
Average Patient Age 49.2 yrs 57.9 yrs
% Female Patients 90.0% 50.0%
FDA Approval Date Apr 22, 2011 Approved Prior to Jan 1, 1982
Manufacturer Hikma Pharmaceuticals USA Inc. Harrow Eye, LLC
Route ORAL OPHTHALMIC
Marketing Status Discontinued Prescription